Antibacterial drug discovery: challenges and preclinical promises from synthetic small molecules

Over the past few decades, antibacterial discovery has changed substantially, yet innovation has remained slow despite the growing need for new agents active against multidrug-resistant pathogens. Progress is constrained by scientific hurdles, including target selection, penetration and efflux in ba